Skip to main content
Clinical Trials/JPRN-jRCT1012230026
JPRN-jRCT1012230026
Recruiting
Phase 2

Exploratory Clinical Trial: Low Frequency Therapy for Interstitial Pneumonia

Konno satoshi0 sites30 target enrollmentStarted: July 29, 2023Last updated:

Overview

Phase
Phase 2
Status
Recruiting
Sponsor
Konno satoshi
Enrollment
30

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
>= 18age old to ot applicable (—)

Inclusion Criteria

  • Patients with interstitial pneumonia who are attending or being admitted to Hokkaido University Hospital (Respiratory Medicine) between the date of approval for implementation and January 31, 2028\.
  • Patients who meet all of the following criteria are eligible.
  • (i) Patients who are 18 years of age or older at the time of informed consent.
  • (ii) Patients who have been clinically diagnosed as having interstitial pneumonia by chest imaging or respiratory function tests, whose arterial partial pressure of oxygen at rest is less than 70 Torr or less than 80 Torr, and whose SpO2 drops to less than 90% in a 6\-minute walk test.
  • (iii) Subjects with subjective symptoms such as shortness of breath or dyspnea.
  • (iv) After receiving a thorough explanation of their participation in this study, participants must be able to actively understand the consent document and give written consent of their own free will.

Exclusion Criteria

  • Patients with any one of the following conditions shall be excluded
  • (i) Patients who have had acute heart failure, myocardial infarction, pulmonary edema, or acute exacerbation of interstitial pneumonia within the past 3 months
  • (ii) Patients with a history of progressive brain lesions
  • (iii) Patients receiving concomitant vagus nerve stimulation therapy
  • (iv) Patients with a history of epilepsy
  • (5\) Patients with a history of severe cardiovascular disease
  • (vi) Patients with pneumothorax
  • (vii) Patients with uncontrolled infection
  • (viii) Pregnant or lactating
  • (ix) Patients with skin hypersensitivity and a history of skin symptoms caused by metal or other substances

Investigators

Sponsor
Konno satoshi

Similar Trials